Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Director departure Appointed director
|
EAGLE PHARMACEUTICALS, INC. (EGRX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/10/2018 |
BW
| Eagle Pharmaceuticals, Inc. Reports First Quarter 2018 Results |
05/01/2018 |
BW
| Eagle Pharmaceuticals, Inc. to Discuss First Quarter 2018 Financial Results on May 10, 2018 |
02/26/2018 |
BW
| Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2017 Results |
02/15/2018 |
BW
| Eagle Pharmaceuticals, Inc. to Discuss Fourth Quarter and Year End 2017 Financial Results on February 26, 2018 |
02/12/2018 |
BW
| Eagle Pharmaceuticals, Inc. to Present at 2018 RBC Capital Markets Global Healthcare Conference |
01/02/2018 |
BW
| Eagle Pharmaceuticals, Inc. to Present at 36th Annual J.P. Morgan Healthcare Conference |
11/08/2017 |
BW
| Eagle Pharmaceuticals, Inc. Reports Third Quarter 2017 Results |
10/17/2017 |
BW
| Eagle Pharmaceuticals Announces New Patent for RYANODEX |
09/06/2017 |
BW
| Eagle Pharmaceuticals, Inc. to Present at September Investor Conferences |
08/09/2017 |
BW
| Eagle Pharmaceuticals, Inc. Reports Second Quarter 2017 Results |
07/31/2017 |
BW
| Eagle Pharmaceuticals, Inc. to Discuss Second Quarter 2017 Financial Results on August 9, 2017 |
05/31/2017 |
BW
| Eagle Pharmaceuticals, Inc. to Present at Investor Conferences in June |
05/08/2017 |
BW
| Eagle Pharmaceuticals, Inc. Reports First Quarter 2017 Results |
04/25/2017 |
BW
| Eagle Pharmaceuticals, Inc. to Discuss First Quarter 2017 Financial Results on May 8, 2017 |
04/24/2017 |
BW
| Eagle Pharmaceuticals, Inc. to Present at 42nd Annual Deutsche Bank Health Care Conference |
03/01/2017 |
BW
| Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2016 Results |
02/28/2017 |
BW
| Eagle Pharmaceuticals' Pemetrexed NDA Accepted for Filing by the FDA |
02/16/2017 |
BW
| Eagle Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2016 Financial Results on March 1, 2017 |
02/13/2017 |
BW
| Eagle Pharmaceuticals to Present at 2017 RBC Capital Markets Global Healthcare Conference |
|
|